Overview

Comparison of Rimegepant and Placebo for Pain in IBS

Status:
COMPLETED
Trial end date:
2025-06-03
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to evaluate the efficacy of rimegepant on abdominal pain scores in participants with non-constipation IBS.
Phase:
PHASE2
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
Pfizer
Treatments:
rimegepant sulfate